Skip to main content

Enhancement of Hyperthermia on Anti-tumor Drug Sensitivity

  • Chapter
  • First Online:
Hyperthermic Oncology from Bench to Bedside

Abstract

Anti-tumor drugs have been utilized in combination with hyperthermia, synergistic effects have been observed, and efforts have been made to explain the basis for these observations. It is thought that the initial extent of DNA damage is enhanced by hyperthermia effects, and this outcome is associated with tissue blood flow. If this is true, then an associated effect would be an additional increase in DNA damage induced by anti-tumor drugs. Another hypothesized mechanism is that DNA repair enzyme activity required for repair of DNA damage is depressed by a heat exposure. A third hypothesis is that more efficient cell killing is induced by the induction of cell death signaling pathways and the depression of cell survival signaling pathways through hyperthermia (Fig. 10.1). In this chapter, the main focus is on the increase in activity of anti-tumor drugs induced by hyperthermia. DNA repair inhibition induced by hyperthermia has been described in other chapters.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hahn GM. Potential for therapy of drugs and hyperthermia. Cancer Res. 1979;39:2264–8.

    CAS  PubMed  Google Scholar 

  2. Ning S, Hahn GM. Combination therapy: lonidamine, hyperthermia, and chemotherapy against the RIF-1 Tumor in vivo. Cancer Res. 1991;51:5910–14.

    CAS  PubMed  Google Scholar 

  3. Meyn RE, et al. Thermal enhancement of DNA damage in mammalian cells treated with cis-diamminedichloroplatinum(II). Cancer Res. 1980;40:1136–9.

    CAS  PubMed  Google Scholar 

  4. Yano T, et al. Hyperthermic enhancement of cis-diamminedichloroplatinum (II)-induced DNA damage in human esophageal cancer transplantable to nude mice. Anticancer Res. 1993;13:1989–97.

    CAS  PubMed  Google Scholar 

  5. Xu Q, et al. Nanotechnology approaches for ocular drug delivery. Middle East Afr J Ophthalmol. 2013;20:26–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Zhang J, et al. In vivo anti-tumor efficacy of docetaxel-loaded thermally responsive nanohydrogel. Nanotechnology. 2009;20:325102.

    Article  PubMed  Google Scholar 

  7. Kossatz S, et al. Efficient treatment of breast cancer xenografts with multi-functionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery. Breast Cancer Res. 2015;17:66.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Mura S, et al. Stimuli-responsive nanocarriers for drug delivery. Nat Mater. 2013;12:991–1003.

    Article  CAS  PubMed  Google Scholar 

  9. Puri A, et al. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit Rev Ther Drug Carrier Syst. 2009;26:523–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Kong G, et al. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res. 2000;60:6950–7.

    CAS  PubMed  Google Scholar 

  11. Chen KJ, et al. Hyperthermia-mediated local drug delivery by a bubble-generating liposomal system for tumor-specific chemotherapy. ACS Nano. 2014;8:5105–15.

    Article  CAS  PubMed  Google Scholar 

  12. Ponce AM, et al. Hyperthermia mediated liposomal drug delivery. Int J Hyperthermia. 2006;222:205–13.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takeo Ohnishi .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media Singapore

About this chapter

Cite this chapter

Ohnishi, T. (2016). Enhancement of Hyperthermia on Anti-tumor Drug Sensitivity. In: Kokura, S., Yoshikawa, T., Ohnishi, T. (eds) Hyperthermic Oncology from Bench to Bedside. Springer, Singapore. https://doi.org/10.1007/978-981-10-0719-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-0719-4_10

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-0717-0

  • Online ISBN: 978-981-10-0719-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics